CONSOLIDATED INCOME STATEMENT
Download table
|
Notes |
53 weeks ended 3 May 2009 £’000 |
52 weeks ended 27 April 2008 restated note (i) £’000 |
||
|---|---|---|---|---|---|
Continuing operations |
|
|
|
||
Revenue including share of joint venture revenues |
|
360,000 |
324,182 |
||
Less: share of joint venture revenues |
|
(14,211) |
(15,485) |
||
Group revenue |
|
345,789 |
308,697 |
||
Cost of sales |
|
(216,269) |
(195,038) |
||
Gross profit |
|
129,520 |
113,659 |
||
Administrative expenses |
|
(122,007) |
(96,602) |
||
Share of result of joint ventures |
|
3,210 |
1,538 |
||
Operating profit |
10,723 |
18,595 |
|||
Finance income |
14,734 |
14,642 |
|||
Finance costs |
(16,051) |
(13,489) |
|||
Profit before taxation |
|
9,406 |
19,748 |
||
Taxation |
(1,645) |
(6,346) |
|||
Profit for the period |
|
7,761 |
13,402 |
||
Attributable to: |
|
|
|
||
Equity holders of the Company |
|
7,693 |
13,298 |
||
Minority interests |
|
68 |
104 |
||
|
|
7,761 |
13,402 |
||
Earnings per share: |
|
|
|
||
From continuing operations – basic |
10.27p |
17.74p |
|||
From continuing operations – diluted |
10.17p |
17.09p |
There were no discontinued operations in either period.
The Directors have presented a more detailed Income Statement in note 5.
Note (i): Restated for the revised presentation of changes in the fair value of exchange rate derivative financial instruments, as detailed further in note 12.